dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Planas Vilaseca, Alejandra |
dc.contributor.author | Simó Servat, Olga |
dc.contributor.author | Hernández Pascual, Cristina |
dc.contributor.author | Ortiz Zuñiga, Angel Michael |
dc.contributor.author | Herance Camacho, José Raul |
dc.contributor.author | Ferreira González, Ignacio |
dc.contributor.author | Simó Canonge, Rafael |
dc.contributor.author | Marsal Mora, Josep Ramon |
dc.date.accessioned | 2022-06-15T12:53:23Z |
dc.date.available | 2022-06-15T12:53:23Z |
dc.date.issued | 2021-12 |
dc.identifier.citation | Planas A, Simó-Servat O, Hernández C, Ortiz-Zúñiga Á, Marsal JR, Herance JR, et al. Diabetic Retinopathy and Skin Tissue Advanced Glycation End Products Are Biomarkers of Cardiovascular Events in Type 2 Diabetic Patients. J Pers Med. 2021 Dec;11(12):1344. |
dc.identifier.issn | 2075-4426 |
dc.identifier.uri | https://hdl.handle.net/11351/7689 |
dc.description | Biomarcadors de malalties cardiovasculars; Complicacions de la diabetis; Diabetis tipus 2 |
dc.description.sponsorship | This research was funded by grants from the Spanish Institute of Health (ISCIII) in the setting of Integrative Excellence Projects (PIE 2013/27) and the European Foundation for the Study of Diabetes (EFSD Pilot Research Grant Programme for Innovative Measurement of Diabetes Outcomes 2017). The study funders were not involved in the design of the study. |
dc.language.iso | eng |
dc.publisher | MDPI |
dc.relation.ispartofseries | Journal of Personalized Medicine;11(12) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Retinopatia diabètica |
dc.subject | Glicosilació |
dc.subject | Cor - Malalties - Factors de risc |
dc.subject.mesh | Diabetic Retinopathy |
dc.subject.mesh | Glycation End Products, Advanced |
dc.subject.mesh | Cardiovascular Diseases |
dc.subject.mesh | /diagnosis |
dc.title | Diabetic Retinopathy and Skin Tissue Advanced Glycation End Products Are Biomarkers of Cardiovascular Events in Type 2 Diabetic Patients |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3390/jpm11121344 |
dc.subject.decs | retinopatía diabética |
dc.subject.decs | productos finales de la glicación avanzada |
dc.subject.decs | enfermedades cardiovasculares |
dc.subject.decs | /diagnóstico |
dc.relation.publishversion | https://doi.org/10.3390/jpm11121344 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Planas A, Simó-Servat O, Hernández C, Ortiz-Zúñiga Á, Simó R] Unitat de Recerca en Diabetis i Metabolisme, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Spanish Institute of Health (ISCIII), 28029 Madrid, Spain. [Marsal JR, Ferreira-González I] Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. CIBER en Epidemiología y Salud Pública (CIBERESP), Spanish Institute of Health (ISCIII), 28029 Madrid, Spain. [Hernández C] Grup de Recerca en Imatge Molecular Mèdica, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei de Medicina Nuclear, Vall d’Hebron Hospital Universitari, Barcelona, Spain. CIBBIM-Nanomedicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. CIBERBBN, Spanish Institute of Health (ISCIII), 28029 Madrid, Spain |
dc.identifier.pmid | 34945815 |
dc.identifier.wos | 000738266800001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |